List of works - Michael Carpenter

A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.

scientific article published on 21 October 2015

APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

scientific article published on 17 December 2013

APOBEC3B is an enzymatic source of mutation in breast cancer.

scientific article published on 06 February 2013

APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.

scientific article published on 23 October 2013

Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B.

scientific article

Cryo-EM structure of the EBV ribonucleotide reductase BORF2 and mechanism of APOBEC3B inhibition

scientific article published on 27 April 2022

Crystal Structure of the DNA Cytosine Deaminase APOBEC3F: The Catalytically Active and HIV-1 Vif-Binding Domain

scientific article

DNA base flipping by both members of the PspGI restriction-modification system

scientific article published on 20 August 2008

Determinants of Oligonucleotide Selectivity of APOBEC3B

scientific article published on 10 September 2018

Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic.

scientific article published on 02 May 2013

First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G

scientific article

HIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1

scientific article published on 30 May 2019

Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.

scientific article

Oxidative Reactivities of 2-Furylquinolines: Ubiquitous Scaffolds in Common High-Throughput Screening Libraries.

scientific article published on 11 September 2015

Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B.

scientific article published on 19 December 2016

The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism.

scientific article published on 27 December 2017

The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis.

scientific article published on 21 September 2016

The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution.

scientific article published on 11 August 2013

List of works by Michael Carpenter

A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.

APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

APOBEC3B is an enzymatic source of mutation in breast cancer.

APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.

Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B.

Cryo-EM structure of the EBV ribonucleotide reductase BORF2 and mechanism of APOBEC3B inhibition

Crystal Structure of the DNA Cytosine Deaminase APOBEC3F: The Catalytically Active and HIV-1 Vif-Binding Domain

DNA base flipping by both members of the PspGI restriction-modification system

Determinants of Oligonucleotide Selectivity of APOBEC3B

Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic.

First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G

HIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1

Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.

Oxidative Reactivities of 2-Furylquinolines: Ubiquitous Scaffolds in Common High-Throughput Screening Libraries.

Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B.

The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism.

The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis.

The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution.